JP2021138710A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021138710A5 JP2021138710A5 JP2021081095A JP2021081095A JP2021138710A5 JP 2021138710 A5 JP2021138710 A5 JP 2021138710A5 JP 2021081095 A JP2021081095 A JP 2021081095A JP 2021081095 A JP2021081095 A JP 2021081095A JP 2021138710 A5 JP2021138710 A5 JP 2021138710A5
- Authority
- JP
- Japan
- Prior art keywords
- drug
- eye diseases
- diabetic
- rpe
- pvr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 claims 3
- 229940079593 drugs Drugs 0.000 claims 3
- 206010064930 Age-related macular degeneration Diseases 0.000 claims 2
- 206010012688 Diabetic retinal oedema Diseases 0.000 claims 2
- 206010012689 Diabetic retinopathy Diseases 0.000 claims 2
- 208000009745 Eye Disease Diseases 0.000 claims 2
- 208000002780 Macular Degeneration Diseases 0.000 claims 2
- 208000002158 Proliferative Vitreoretinopathy Diseases 0.000 claims 2
- 206010038934 Retinopathy proliferative Diseases 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 201000011190 diabetic macular edema Diseases 0.000 claims 2
- 206010061218 Inflammation Diseases 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 230000004386 ocular blood flow Effects 0.000 claims 1
- 239000000790 retinal pigment Substances 0.000 claims 1
Claims (2)
- 有効量の、式I：
眼疾患が、増殖性硝子体網膜症（PVR）、ブドウ膜炎、加齢黄斑変性症（AMD）の初期事象、糖尿病網膜症（DR）および糖尿病黄斑浮腫（DME）からなる群より選択される、医薬。 - 該医薬が1日1〜3回経口投与され、式Iで示される化合物の量が、各経口投与において0.5〜50mgである、請求項1に記載の医薬。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023100597A JP2023116748A (ja) | 2016-09-29 | 2023-06-20 | 眼疾患の処置方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662401725P | 2016-09-29 | 2016-09-29 | |
| US62/401,725 | 2016-09-29 | ||
| JP2019517058A JP2019531296A (ja) | 2016-09-29 | 2017-09-29 | 眼疾患の処置方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019517058A Division JP2019531296A (ja) | 2016-09-29 | 2017-09-29 | 眼疾患の処置方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023100597A Division JP2023116748A (ja) | 2016-09-29 | 2023-06-20 | 眼疾患の処置方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021138710A JP2021138710A (ja) | 2021-09-16 |
| JP2021138710A5 true JP2021138710A5 (ja) | 2021-12-23 |
Family
ID=61688114
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019517058A Withdrawn JP2019531296A (ja) | 2016-09-29 | 2017-09-29 | 眼疾患の処置方法 |
| JP2021081095A Pending JP2021138710A (ja) | 2016-09-29 | 2021-05-12 | 眼疾患の処置方法 |
| JP2023100597A Pending JP2023116748A (ja) | 2016-09-29 | 2023-06-20 | 眼疾患の処置方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019517058A Withdrawn JP2019531296A (ja) | 2016-09-29 | 2017-09-29 | 眼疾患の処置方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023100597A Pending JP2023116748A (ja) | 2016-09-29 | 2023-06-20 | 眼疾患の処置方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11045435B2 (ja) |
| EP (1) | EP3518913A4 (ja) |
| JP (3) | JP2019531296A (ja) |
| KR (1) | KR102341446B1 (ja) |
| CN (1) | CN109789115A (ja) |
| CA (1) | CA3038845C (ja) |
| TW (1) | TWI765917B (ja) |
| WO (1) | WO2018059543A1 (ja) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110585196B (zh) * | 2018-06-13 | 2022-11-04 | 郭涛 | 一种治疗及预防眼科疾病的药物及其应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060074100A1 (en) * | 2002-11-12 | 2006-04-06 | Klimko Peter G | Histone deacetylase inhibitors for the treatment of ocular neovascular or edematous disorders and diseases |
| US20050074497A1 (en) * | 2003-04-09 | 2005-04-07 | Schultz Clyde L. | Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases |
| JP4873904B2 (ja) * | 2005-08-22 | 2012-02-08 | 国立大学法人弘前大学 | 眼血管血流障害改善剤 |
| CN101646460A (zh) | 2007-03-28 | 2010-02-10 | 参天制药株式会社 | 含有具有组蛋白脱乙酰化酶抑制作用的化合物作为有效成分的降眼压剂 |
| CA2630174A1 (en) * | 2007-05-02 | 2008-11-02 | Mitchell Alan Winnik | Loading quantum dots into thermo-responsive microgels by reversible transfer from organic solvents to water |
| US20110014294A1 (en) | 2008-03-03 | 2011-01-20 | Pharmalight Inc. | Stimulation of ocular retrobulbar blood flow using ocular irritants |
| NZ591820A (en) * | 2008-08-27 | 2012-12-21 | Leo Pharma As | Pyridine derivatives as vegfr-2 receptor and protein tyrosine kinase inhibitors |
| ES2473792T3 (es) * | 2009-04-03 | 2014-07-07 | Naturewise Biotech & Medicals Corporation | Compuestos cin�micos y derivados de los mismos para la inhibición de la histona desacetilasa |
| US7994357B2 (en) * | 2009-04-03 | 2011-08-09 | Naturewise Biotech & Medicals Corporation | Cinamic compounds and derivatives therefrom for the inhibition of histone deacetylase |
| EP2277387B1 (en) * | 2009-07-22 | 2016-10-19 | NatureWise Biotech & Medicals Corporation | New use of histone deacetylase inhibitors in changing mrjp3 protein in royal jelly |
| KR102165421B1 (ko) * | 2011-05-09 | 2020-10-14 | 알레그로 파마슈티칼스, 인코포레이티드. | 인테그린 수용체 길항물질 및 이의 사용 방법 |
| CA2946086A1 (en) * | 2014-04-17 | 2015-10-22 | Teraclon Idf, S.L. | Recombinant monoclonal antibodies vnar neutralizing the vascular endothelial growth factor (vegf) |
| US9956254B2 (en) * | 2015-02-26 | 2018-05-01 | Naturewise Biotech & Medicals Corporation | Extract of taiwanese propolis for treating ocular diseases |
-
2017
- 2017-09-29 EP EP17854993.7A patent/EP3518913A4/en active Pending
- 2017-09-29 JP JP2019517058A patent/JP2019531296A/ja not_active Withdrawn
- 2017-09-29 KR KR1020197009679A patent/KR102341446B1/ko active IP Right Grant
- 2017-09-29 US US15/720,785 patent/US11045435B2/en active Active
- 2017-09-29 WO PCT/CN2017/104345 patent/WO2018059543A1/en unknown
- 2017-09-29 TW TW106133818A patent/TWI765917B/zh active
- 2017-09-29 CN CN201780056308.XA patent/CN109789115A/zh active Pending
- 2017-09-29 CA CA3038845A patent/CA3038845C/en active Active
-
2021
- 2021-05-12 JP JP2021081095A patent/JP2021138710A/ja active Pending
-
2023
- 2023-06-20 JP JP2023100597A patent/JP2023116748A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105307498B (zh) | 用于治疗眼病的组合物、制剂和方法 | |
| CA2899321C (en) | Fluorinated .alpha..nu.integrin antagonists | |
| CN109152774A (zh) | 眼部炎性病症和疾病的组合治疗 | |
| JP2022081661A5 (ja) | ||
| CA3036474A1 (en) | Therapeutic agent for an ophthalmic disease comprising a vegf receptor inhibitor | |
| AU2011334617B2 (en) | Folic acid - Ramipril combination: cellprotective, neuroprotective and retinoprotective ophtalmologic compositions | |
| JP2013500977A5 (ja) | ||
| KR101692578B1 (ko) | 레바미피드 또는 이의 전구체를 포함하는 안구건조증의 예방 또는 치료를 위한 경구용 약제학적 조성물 | |
| CN102164600A (zh) | 用于治疗眼的新血管发生病症的包含索拉菲尼的眼科药物组合物 | |
| EP1938799B1 (en) | Compositions for treating and preventing posterior segment ophthalmic disorders and use thereof | |
| JP2019218379A5 (ja) | ||
| JP2021138710A5 (ja) | ||
| RU2015145134A (ru) | Местное лечение воспалительных офтальмологических заболеваний | |
| RU2017112930A (ru) | Офтальмологические составы для доставки лекарств и защиты переднего отдела глаза | |
| JP2021525710A (ja) | 眼充血を治療するための組成物およびそれを用いて眼充血を治療するための方法 | |
| JP2017527600A5 (ja) | ||
| CN106146558A (zh) | 新的噁唑烷酮类化合物及其制备方法 | |
| WO2023236485A1 (zh) | 一种青蒿素的衍生物及其制备方法与应用 | |
| JP2010260857A (ja) | シロリムス誘導体を有効成分として含有する網脈絡膜疾患の治療剤 | |
| KR20210062586A (ko) | 안질환 예방 또는 치료용 점안 조성물 | |
| JP2018533631A (ja) | 網膜疾患の治療のためのミラベグロン | |
| JP2019534269A5 (ja) | ||
| TW202038934A (zh) | 用於治療癌症之口服投予多西紫杉醇（ｄｏｃｅｔａｘｅｌ）和Ｐ－ｇｐ抑制劑的醫療組合 | |
| JP2020530459A5 (ja) | ||
| US7612082B2 (en) | Prostaglandin EP4 antagonists |